The Leadership Team at KaliVir Immunotherapeutics is responsible for defining the strategic direction of the company, overseeing clinical development, and guiding scientific innovation in cancer treatment. Comprising key executives such as the CEO, CMO, and CSO, the team collaborates to ensure the successful advancement of novel immunotherapeutic approaches, aligning the company's vision with regulatory compliance and market needs. Their collective expertise drives research initiatives, business development, and stakeholder engagement to position KaliVir as a leader in the field of cancer therapeutics.
View all